Search results for "28"

showing 10 items of 3583 documents

2018

Insomnia and obstructive sleep apnea (OSA) are often both present in patients with sleep-disordered-breathing (SDB). The coexistence of the two disorders shows an increase in cumulative morbidity and an overall greater illness severity. There is still considerable controversy regarding management decisions in this group of patients. This systematic review focused on more recent evidence regarding treatment of patients presenting with both clinical entities of comorbid insomnia and OSA (COMISA) in terms of their management, especially using combinations of positive airway pressure [PAP, namely aPAP, cPAP, adaptive servo-ventilation (ASV)] and CBTi as well as each one of these two modalities …

medicine.medical_specialtyModalitiesComorbid insomniabusiness.industrymedicine.medical_treatmentSleep apneamedicine.diseasenervous system diseasesrespiratory tract diseasesCognitive behavioral therapyObstructive sleep apnea03 medical and health sciences0302 clinical medicine030228 respiratory systemNeurologymental disordersPositive airway pressureInsomniaMedicineIn patientNeurology (clinical)medicine.symptombusinessIntensive care medicine030217 neurology & neurosurgeryFrontiers in Neurology
researchProduct

Sleep apnea and its role in transportation safety

2017

Obstructive sleep apnea (OSA) is a main cause of excessive daytime sleepiness and increases the risk for driving accidents, which can be normalized by treatment with continuous positive airway pressure ventilation. Since it is estimated that OSA is not diagnosed in about 80% of cases, recognition of patients at risk for driving accidents is a problem from both medical and societal points of view. Strategies to screen and identify subjects at high risk for driving accidents are under study in order to improve safety on the road, especially for commercial drivers, who show a high prevalence of OSA.

medicine.medical_specialtyObstructive Sleep Apneamedicine.medical_treatmentTransportation safetyExcessive daytime sleepinessReviewSettore MED/10 - Malattie Dell'Apparato RespiratorioGeneral Biochemistry Genetics and Molecular Biologylaw.invention03 medical and health sciences0302 clinical medicinelawCPAPAnesthesiologyDriving accidentmedicineContinuous positive airway pressureGeneral Pharmacology Toxicology and PharmaceuticsOpen peer reviewGeneral Immunology and Microbiologydriving accidentsSleep apneaArticlesGeneral MedicineSleep disordersmedicine.diseaserespiratory tract diseasesObstructive sleep apnea030228 respiratory systemEmergency medicineVentilation (architecture)medicine.symptom030217 neurology & neurosurgery
researchProduct

Topical therapies for oral lichen planus management and their efficacy: a narrative review.

2012

Oral Lichen Planus (OLP) is a chronic inflammatory condition implicating T cell-mediated cytotoxicity, and involving oral mucosal surfaces. Several therapeutic regimens have been evaluated to treat OLP and pain related, but often without high level of evidence. Topical formulations are the favourite for the majority of cases; bioadhesive formulations have been considered very useful and practical for local drug delivery in oral mucosa, due to the increased residence time on the oral mucosa of the dosage forms and better therapeutic efficacy. In this narrative review, authors try to illustrate the current topical managements for OLP from the accessible literature on this topic. Steroids are …

medicine.medical_specialtyOral Lichen Planus topical therapy corticosteroids aloe vera retinoids hyaluronic acid phototherapy laser therapy.Time FactorsBasiliximabHyaluronic acidAdministration TopicalEfalizumabPimecrolimusRetinoidsDrug Delivery Systemsstomatognathic systemSettore MED/28 - Malattie OdontostomatologicheDrug DiscoveryOral and maxillofacial pathologymedicineCorticosteroidsHumansAloe vera; Corticosteroids; Hyaluronic acid; Laser therapy; Oral lichen planus; Phototherapy; Retinoids; Topical therapy; Drug Discovery3003 Pharmaceutical Science; PharmacologyPharmacologybusiness.industryDrug Discovery3003 Pharmaceutical ScienceMouth MucosaPhototherapymedicine.diseaseDermatologyAloe veraAlefaceptTacrolimusInfliximabstomatognathic diseasesPhotopheresisOral lichen planusQuality of LifeTopical therapyOral lichen planusLaser Therapybusinessmedicine.drugLichen Planus Oral
researchProduct

Mepolizumab for eosinophilic chronic obstructive pulmonary disease

2017

BACKGROUNDPatients with chronic obstructive pulmonary disease (COPD) with an eosinophilic phenotype may benefit from treatment with mepolizumab, a monoclonal antibody directed against interleukin-5.METHODSWe performed two phase 3, randomized, placebo-controlled, double-blind, parallel-group trials comparing mepolizumab (100 mg in METREX, 100 or 300 mg in METREO) with placebo, given as a subcutaneous injection every 4 weeks for 52 weeks in patients with COPD who had a history of moderate or severe exacerbations while taking inhaled glucocorticoid-based triple maintenance therapy. In METREX, unselected patients in the modified intention-to-treat population with an eosinophilic phenotype were …

medicine.medical_specialtyPARALLEL-GROUPPopulationPlacebo-controlled studyPNEUMONIA RISKPlaceboPLACEBO-CONTROLLED TRIALGastroenterology03 medical and health sciencesDOUBLE-BLIND0302 clinical medicineMaintenance therapyInternal medicineEosinophilicmedicineINHALED FLUTICASONE FUROATE030212 general & internal medicineeducationCOPDeducation.field_of_studyIntention-to-treat analysisCOPD ASSESSMENT TESTSPUTUM EOSINOPHILIAbusiness.industryGeneral MedicineRANDOMIZED CONTROLLED-TRIALBLOOD EOSINOPHILSmedicine.diseaseSECONDARY ANALYSIS030228 respiratory systemImmunologybusinessMepolizumabmedicine.drug
researchProduct

Application of palliative ventilation: potential and clinical evidence in palliative care.

2017

medicine.medical_specialtyPalliative carebusiness.industryNursing researchPain medicineMEDLINElaw.invention03 medical and health sciences0302 clinical medicine030228 respiratory systemOncologylawClinical evidenceVentilation (architecture)medicine030212 general & internal medicineIntensive care medicinebusinessSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
researchProduct

A rare case of oral multisystem Langerhans cell histiocytosis

2017

Langerhans cell histiocytosis (LCH) is a rare disorder characterized by high proliferation of Langerhans dendritic cells. LCH is a solitary or multifocal disease that primarily involves bone tissue and often affects children and young men. A 29 years-old Caucasian man was referred to the Oral Surgery Unit of George Eastman Hospital - Umberto I teaching hospital, with third degree mobility of teeth belonging to second, third and fourth quadrant. Panoramic radiograph showed multiple radiolucent areas with well demarcated borders on the right and left site of the mandible and on the left site of the maxilla. Extractions of compromised teeth and biopsy of the osteolytic tissue were performed. T…

medicine.medical_specialtyPanoramic radiographDifferential diagnosis; Langerhans cell histiocytosis; Microscopic diagnosis; Dentistry (all)Case ReportSettore MED/28 - MALATTIE ODONTOSTOMATOLOGICHE03 medical and health sciencesQuadrant (abdomen)0302 clinical medicineLangerhans cell histiocytosisRare caseBiopsymedicineGeneral DentistryOral Medicine and Pathologymedicine.diagnostic_testbusiness.industrySoft tissueLangerhans cell histiocytosis030206 dentistryMicroscopic diagnosismedicine.disease:CIENCIAS MÉDICAS [UNESCO]DermatologySurgery030220 oncology & carcinogenesisMaxillaUNESCO::CIENCIAS MÉDICASDentistry (all)Proper treatmentDifferential diagnosisbusiness
researchProduct

Neurophysiological evaluation of visual function in iRBD: potential role in stratifying RBD conversion risk.

2021

Abstract Study objectives To evaluate neurophysiological alterations of visual function in idiopathic REM sleep Behavior Disorder (iRBD) both as markers and predictors of neurodegenerative disorders. Methods In a longitudinal follow-up study of 46 consecutive iRBD patients (follow-up duration 8.4 ± 3.4 years), the baseline parameters in luminance-contrast pattern (VEPp), red-green color (VEPc) and motion-onset (VEPm) Visual Evoked Potentials in iRBD were compared to early (ePD) and advanced (aPD) Parkinson's Disease subjects. Parameters of latency and amplitude of iRBD converters to neurodegenerative disease were compared with those of the non-converters. Results The VEP P100 mean latency v…

medicine.medical_specialtyParkinson's diseasegenetic structuresEvoked potentials; Neurodegenerative disorders; Neurophysiology; Parkinson's disease; Phenoconversion risk; REM sleep Behavior disorderParkinson's diseaseNeurophysiologyVisual evoked potentialsREM Sleep Behavior DisorderAudiologyREM sleep behavior disorder03 medical and health sciences0302 clinical medicinemedicineHumansbusiness.industryNeurodegenerative DiseasesParkinson DiseaseGeneral MedicineEvoked potentialsNeurophysiologymedicine.disease030228 respiratory systemVisual functionNeurodegenerative disordersEvoked Potentials VisualPhenoconversion riskbusiness030217 neurology & neurosurgeryFollow-Up StudiesSleep medicine
researchProduct

The Burden of Pediatric Asthma

2018

Asthma is the most common chronic disease in children, imposing a consistent burden on health system. In recent years, prevalence of asthma symptoms became globally increased in children and adolescents, particularly in Low-Middle Income Countries (LMICs). Host (genetics, atopy) and environmental factors (microbial exposure, exposure to passive smoking and air pollution), seemed to contribute to this trend. The increased prevalence observed in metropolitan areas with respect to rural ones and, overall, in industrialized countries, highlighted the role of air pollution in asthma inception. Asthma accounts for 1.1% of the overall global estimate of "Disability-adjusted life years" (DALYs)/100…

medicine.medical_specialtyPassive smokingTotal costMini ReviewprevalencemorbidityDiseasemedicine.disease_causePediatricsburden03 medical and health sciencesIndirect costs0302 clinical medicineQuality of life (healthcare)childrenEnvironmental healthEpidemiologycostMedicine030212 general & internal medicineAsthmabusiness.industrylcsh:RJ1-570lcsh:Pediatricsasthmamedicine.diseasemortality030228 respiratory systemPediatrics Perinatology and Child HealthepidemiologybusinessDeveloped countryFrontiers in Pediatrics
researchProduct

Metabolomics of chronic obstructive pulmonary disease and obstructive sleep apnea syndrome : response to Maniscalco and Motta

2016

We appreciate Maniscalco and Motta’s comments on our recently published article “Fusion of the 1H NMR data of serum, urine and exhaled breath condensate in order to discriminate chronic obstructive pulmonary disease and obstructive sleep apnea syndrome” (Zabek et al. 2015) and we are grateful for the opportunity to clarify a number of points from our work. We are glad that the authors appreciated our data analysis and interpretation. Fusion of metabolomic data is an outstanding tool for a comprehensive description of patient’s phenotype that combines metabolic profiles acquired in different domains. Such an integrative approach is highly valued in the so-called ‘breathomics’ (Smolinska et a…

medicine.medical_specialtyPathologyEndocrinology Diabetes and MetabolismClinical BiochemistryDisease01 natural sciencesBiochemistry03 medical and health sciences0302 clinical medicineblood analysismedicineExhaled breath condensatebreath analysisIntensive care medicineLetter to the EditorPathologicalCOPDbusiness.industry010401 analytical chemistryOverlap syndromemedicine.diseaseObesity0104 chemical sciencesClinical trialObstructive sleep apnea030228 respiratory systembusiness
researchProduct

Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.

2016

Abstract Background Hereditary angioedema (HAE) is a rare disease characterized by C1-esterase inhibitor (C1-INH) deficiency, resulting in periodic attacks of acute edema, which can be life-threatening if they occur in the upper airway. No head-to-head comparisons of different treatment options for acute HAE attacks are available. Because immediate symptom relief is critical for potentially life-threatening laryngeal attacks, it is important to determine the treatment option that provides optimal treatment response. Objective Review and compare data from clinical studies that evaluated the efficacy and safety of treatments for laryngeal HAE attacks. Methods We conducted an indirect comparis…

medicine.medical_specialtyPathologyefficacyLaryngeal Diseases03 medical and health sciencesEcallantidechemistry.chemical_compound0302 clinical medicineSymptom reliefIcatibantInternal medicinemedicineHumans030212 general & internal medicineProspective cohort studyC1 esterase inhibitor deficiencybusiness.industryHAEAngioedemas Hereditarymedicine.diseaselaryngealTreatment Outcome030228 respiratory systemchemistryHereditary angioedemaEmergency MedicineC1-INHre-dosingbusinessAirwayComplement C1 Inhibitor Proteinmedicine.drugRare diseaseThe Journal of emergency medicine
researchProduct